galactose has been researched along with cycloastragenol in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dan, J; Gao, D; Liu, D; Liu, J; Luo, Y; Peng, L; Zhou, R | 1 |
| Du, M; Hu, W; Li, J; Li, L; Liu, Y; Luo, S; Wu, J; Yang, Y; Yao, W; Yu, Y; Zheng, X; Zhou, L | 1 |
2 other study(ies) available for galactose and cycloastragenol
| Article | Year |
|---|---|
The protective effect of cycloastragenol on aging mouse circadian rhythmic disorder induced by d-galactose.
Topics: Aging; Animals; ARNTL Transcription Factors; Chronobiology Disorders; Galactose; Mice; Mice, Transgenic; Period Circadian Proteins; Sapogenins | 2019 |
Cycloastragenol prevents age-related bone loss: Evidence in d-galactose-treated and aged rats.
Topics: 3T3 Cells; Age Factors; Animals; Bone Density Conservation Agents; Bone Remodeling; Disease Models, Animal; Female; Femur; Galactose; Male; Membrane Glycoproteins; Mice; Osteoclasts; Osteogenesis; Osteoporosis; Rats, Sprague-Dawley; Sapogenins; Up-Regulation | 2020 |